As previously reported, Barclays analyst Charles Pitman-King downgraded Dialight (DIALF) to Underweight from Equal Weight with a EUR 60 price target as the firm transferred coverage of European Life Sciences to a new analyst. The firm cites reimbursement headwinds to the diagnostics subsector, competition headwinds in the respiratory franchise and below-consensus growth forecasts for its downgrade.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DIALF: